Print Page     Close Window     

SEC Filings

S-8
SERES THERAPEUTICS, INC. filed this Form S-8 on 03/06/2019
Entire Document
 


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 6th day of March, 2019.

 

SERES THERAPEUTICS, INC.

By:   /s/ Eric D. Shaff
 

Eric D. Shaff

President and Chief Executive Officer

POWER OF ATTORNEY AND SIGNATURES

We, the undersigned officer and directors of Seres Therapeutics, Inc. (the “Company”), hereby severally constitute and appoint the Chief Executive Officer of the Company, who is currently Eric D. Shaff and the Chief Legal Officer of the Company, who is currently Thomas J. DesRosier, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Roger J. Pomerantz

Roger J. Pomerantz, M.D.

   Chairman of the Board   March 6, 2019

/s/ Eric D. Shaff

Eric D. Shaff

   President, Chief Executive Officer and Director (Principal Executive Officer and Principal Financial and Accounting Officer)   March 6, 2019

/s/ Noubar B. Afeyan

Noubar B. Afeyan, Ph.D.

  

Director

  March 6, 2019

/s/ Dennis A. Ausiello

Dennis A. Ausiello, M.D.

  

Director

  March 6, 2019

/s/ Grégory Behar

Grégory Behar

  

Director

  March 6, 2019

/s/ Willard H. Dere

Willard H. Dere, M.D.

  

Director

  March 6, 2019

/s/ Kurt C. Graves

Kurt C. Graves

  

Director

  March 6, 2019

/s/ Richard N. Kender

Richard N. Kender

  

Director

  March 6, 2019

/s/ Lorence H. Kim

Lorence H. Kim, M.D.

  

Director

  March 6, 2019

/s/ Meryl Zausner

Meryl Zausner

  

Director

  March 6, 2019

© Seres Therapeutics. All Rights Reserved.